
BioNTech Co-founders Depart to Launch New mRNA Venture
The Turkish co-founders of BioNTech are leaving the company to establish a new enterprise focused on next-generation mRNA technology. This move comes as BioNTech continues to record significant achievements.
The Story
Analyzing sources…
Source Diversity
Source Diversity
High (67/100)Sources
BioNTech founders step down to start new venture
Ugur Sahin and Özlem Türeci were instrumental in developing the first COVID-19 vaccine to be approved in the West. Now they say they "are ready to become pioneers once again."
Read full article →


